Bullard Co. USA, a manufacturer of protective equipments, including hard hats, rescue helmets, airline respirators, ambient air pumps and thermal imaging devices used in firefighting, has developed PA30PREP, a system to protect those that treat the patients with SARS, TB and Bird Flu.

For the past 100 years, Bullard Co. USA has focused its efforts on saving lives with quality safety products. From the introduction of the world's first hard hat in 1919 to the latest innovations in powered air purifying respirators (PAPR), the company has always believed in maintaining a niche market. Its R&D, followed by world-class engineering has resulted in high-quality protection the end user deserves.

"As far as infection control is concerned, the possibility of widespread airborne infections is increasing with SARS, TB and Bird Flu. The Bullard PA20 PAPR with a 20LFL loose fitting face piece provides superior protection, comfort and value for the infection control healthcare professionals, while eliminating the need for expensive fit testing," said the company.

All Bullard PAPRs are NIOSH approved. Besides the Intrinsically Safe (IS) model is approved by Factory Manual (FM).

"A lot of pharma companies handling API and chemical manufacturers have benefited from this world class product, especially considering its highest airflow (8 cfm) which increases user comfort and its usage," said, Baylon Sequeira Vaz, chief executive, Vision Safety, Goa, the exclusive importers and distributors of Bullard PAPRs within India. Bullard also has a study of its Asigned Protection Factor (APF) of 1000, Airflow v/s Time Analysis, the NiMH battery comparison and all other technical specifications available in their website (www.bullard.com).